Excelsior Biopharma Inc. 6496.TWO Stock
Excelsior Biopharma Inc. Price Chart
Excelsior Biopharma Inc. 6496.TWO Financial and Trading Overview
Excelsior Biopharma Inc. stock price | 28.2 TWD |
Previous Close | 31.3 TWD |
Open | 31.1 TWD |
Bid | 31.3 TWD x 0 |
Ask | 31.55 TWD x 0 |
Day's Range | 31.05 - 31.65 TWD |
52 Week Range | 25.8 - 36.45 TWD |
Volume | 19.11K TWD |
Avg. Volume | 64.67K TWD |
Market Cap | 1.48B TWD |
Beta (5Y Monthly) | 0.569178 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.98 TWD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | July 13, 2021 |
1y Target Est | N/A |
6496.TWO Valuation Measures
Enterprise Value | 743.03M TWD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.15276 |
Price/Book (mrq) | 1.2519283 |
Enterprise Value/Revenue | 1.083 |
Enterprise Value/EBITDA | -26.867 |
Trading Information
Excelsior Biopharma Inc. Stock Price History
Beta (5Y Monthly) | 0.569178 |
52-Week Change | 11.78% |
S&P500 52-Week Change | 20.43% |
52 Week High | 36.45 TWD |
52 Week Low | 25.8 TWD |
50-Day Moving Average | 32.23 TWD |
200-Day Moving Average | 29.35 TWD |
6496.TWO Share Statistics
Avg. Volume (3 month) | 64.67K TWD |
Avg. Daily Volume (10-Days) | 36.3K TWD |
Shares Outstanding | 46.67M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 61.11% |
% Held by Institutions | 0.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -6.92% |
Operating Margin (ttm) | -5.76% |
Gross Margin | 40.91% |
EBITDA Margin | -4.031% |
Management Effectiveness
Return on Assets (ttm) | -1.45% |
Return on Equity (ttm) | -3.98% |
Income Statement
Revenue (ttm) | 686.09M TWD |
Revenue Per Share (ttm) | 14.96 TWD |
Quarterly Revenue Growth (yoy) | 8.30% |
Gross Profit (ttm) | 287.17M TWD |
EBITDA | -27656000 TWD |
Net Income Avi to Common (ttm) | -47542000 TWD |
Diluted EPS (ttm) | -1.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.07B TWD |
Total Cash Per Share (mrq) | 22.85 TWD |
Total Debt (mrq) | 348.47M TWD |
Total Debt/Equity (mrq) | 29.53 TWD |
Current Ratio (mrq) | 3.062 |
Book Value Per Share (mrq) | 25.281 |
Cash Flow Statement
Operating Cash Flow (ttm) | -44089000 TWD |
Levered Free Cash Flow (ttm) | -39902000 TWD |
Profile of Excelsior Biopharma Inc.
Country | Taiwan |
State | N/A |
City | Taipei |
Address | No.3, Park Street |
ZIP | 11503 |
Phone | 886 2 2655 7568 |
Website | https://www.excelsiorgroup.com.tw |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provides toothpaste, and mouth wash and gel products under the Oral7 name; and food and medical beauty maintenance products. Further, it imports and exports active pharmaceutical ingredients; and engages in the research of technologies, and pharmaceutical technologies transfer and cooperative development and improvement activities. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was incorporated in 1988 and is headquartered in Taipei, Taiwan.
Q&A For Excelsior Biopharma Inc. Stock
What is a current 6496.TWO stock price?
Excelsior Biopharma Inc. 6496.TWO stock price today per share is 28.2 TWD.
How to purchase Excelsior Biopharma Inc. stock?
You can buy 6496.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Excelsior Biopharma Inc.?
The stock symbol or ticker of Excelsior Biopharma Inc. is 6496.TWO.
Which industry does the Excelsior Biopharma Inc. company belong to?
The Excelsior Biopharma Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Excelsior Biopharma Inc. have in circulation?
The max supply of Excelsior Biopharma Inc. shares is 46.99M.
What is Excelsior Biopharma Inc. Price to Earnings Ratio (PE Ratio)?
Excelsior Biopharma Inc. PE Ratio is now.
What was Excelsior Biopharma Inc. earnings per share over the trailing 12 months (TTM)?
Excelsior Biopharma Inc. EPS is -1.98 TWD over the trailing 12 months.
Which sector does the Excelsior Biopharma Inc. company belong to?
The Excelsior Biopharma Inc. sector is Healthcare.